PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141 (Bremelanotide): Research Applications and Quality Assessment

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist being investigated for its potential effects on sexual dysfunction. Unlike drugs that act on the vascular system, PT-141 directly influences sexual desire via the central nervous system. This compound profile provides researchers with a comprehensive overview of PT-141, covering its molecular structure, mechanism of action, research applications, crucial quality markers, potential impurities, and proper storage requirements.

Molecular Structure and Properties

PT-141 is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (?-MSH). Its amino acid sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2. The cyclic structure is formed by a lactam bridge between the Aspartic acid (Asp) and Lysine (Lys) residues. The molecular formula is C₅₀H₆₈N₁₄O₁₀, and its molecular weight is approximately 1025.2 g/mol. The sequence modifications compared to ?-MSH enhance its selectivity for melanocortin receptors, particularly MC3-R and MC4-R.

Mechanism of Action

Bremelanotide exerts its effects by binding to and activating melanocortin receptors (MCRs) in the brain. Specifically, the MC3-R and MC4-R subtypes are believed to play a significant role in sexual function. Activation of these receptors is thought to modulate neurotransmitter release, influencing sexual desire, arousal, and satisfaction. Unlike PDE5 inhibitors (e.g., Sildenafil), which primarily target peripheral vascular effects, PT-141 targets central pathways, making it potentially useful for individuals who do not respond to, or are contraindicated for, PDE5 inhibitors.

Research Applications

PT-141 is primarily being investigated for its potential to treat sexual dysfunction in both men and women. Research areas include:

• Female Sexual Interest/Arousal Disorder (FSIAD): This is the most extensively studied application. Clinical trials have explored PT-141's efficacy in improving sexual desire and reducing distress associated with low sexual interest.
• Erectile Dysfunction (ED): Studies are exploring PT-141 as a potential treatment for ED, particularly in cases where PDE5 inhibitors are ineffective or not tolerated.
• Hypoactive Sexual Desire Disorder (HSDD): Research is investigating PT-141's ability to increase sexual desire in individuals with HSDD.
• Melanocortin Receptor Research: PT-141 serves as a valuable tool for researchers studying the function and regulation of melanocortin receptors in various physiological processes, including energy homeostasis and inflammation.

Quality Markers for PT-141

Ensuring the quality of PT-141 is paramount for reliable research outcomes. Key quality markers include:

1. Peptide Purity

Description: Peptide purity refers to the percentage of the desired peptide sequence in the final product, relative to other peptide-related impurities (truncated sequences, deletion sequences, modified sequences, etc.) and non-peptide impurities (salts, solvents, counterions). Acceptable Range: For most research applications, a purity level of ? 98% is recommended. For highly sensitive studies, >99% purity may be necessary. Analytical Method: High-Performance Liquid Chromatography (HPLC) is the primary method for determining peptide purity. Specifically, reversed-phase HPLC (RP-HPLC) with UV detection at 214 nm (peptide bond absorption) and 280 nm (Trp, Tyr absorption) is commonly used. The purity is calculated by integrating the peak area of the desired peptide and dividing it by the total area of all peaks in the chromatogram. Practical Tip: Request a representative HPLC chromatogram from the supplier before purchasing. Visually inspect the chromatogram for the presence of significant impurity peaks. The chromatogram should show a single, dominant peak corresponding to the desired peptide.

2. Peptide Identity

Description: Peptide identity confirms that the synthesized peptide has the correct amino acid sequence. Acceptable Method: Mass Spectrometry (MS), specifically Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) MS or Electrospray Ionization (ESI) MS, is the gold standard for verifying peptide identity. The measured mass-to-charge ratio (m/z) of the peptide should match the theoretical m/z calculated from the amino acid sequence. A tolerance of +/- 0.1% is generally acceptable. Acceptable Method: Amino Acid Analysis (AAA) provides quantitative information on the amino acid composition of the peptide. The measured molar ratios of each amino acid should be consistent with the expected ratios based on the peptide sequence. AAA is particularly useful for identifying sequence errors or modifications. Practical Tip: Always request MS data from the supplier. Verify that the reported m/z value matches the theoretical m/z of PT-141 (1025.2 g/mol) within the acceptable tolerance. Request AAA data as a secondary confirmation method, if available.

3. Peptide Content

Description: Peptide content refers to the actual amount of peptide present in the sample, taking into account factors like residual water, counterions, and other non-peptide components. A peptide sample is rarely 100% peptide by weight. Acceptable Range: Peptide content is typically expressed as a percentage. The acceptable range depends on the intended application, but a content of ? 80% is generally considered acceptable. A higher content is always preferable. Analytical Method: Quantitative Amino Acid Analysis (qAAA) is the most accurate method for determining peptide content. This involves hydrolyzing the peptide sample into its constituent amino acids and then quantifying each amino acid using HPLC. The peptide content is calculated based on the measured amount of each amino acid and the known amino acid composition of the peptide. Analytical Method: Elemental analysis (CHN analysis) can provide information about the carbon, hydrogen, and nitrogen content of the peptide sample. This data can be used to estimate the peptide content, although it is less accurate than qAAA. Practical Tip: Ask the supplier to provide the peptide content as determined by qAAA or elemental analysis. This information is crucial for accurately preparing peptide solutions and ensuring consistent results.

4. Water Content

Description: Peptides are hygroscopic and can absorb water from the atmosphere. Excessive water content can affect peptide stability and lead to inaccurate concentration measurements. Acceptable Range: The water content should ideally be ? 10%. Analytical Method: Karl Fischer titration is the standard method for determining water content. This technique involves a chemical reaction between water and iodine, which is monitored electrochemically. Practical Tip: Request the water content data from the supplier. Store the peptide in a tightly sealed container with a desiccant to minimize water absorption.

5. Counterion Content

Description: Peptides are typically synthesized and purified as salts, with counterions (e.g., TFA, acetate, chloride) balancing the charge of the peptide. The presence of counterions contributes to the overall weight of the peptide sample and must be considered when preparing solutions. Acceptable Range: The type and amount of counterion can vary depending on the purification process. The supplier should provide information about the counterion present and its approximate percentage. Analytical Method: Ion chromatography (IC) can be used to quantify the amount of counterion present in the peptide sample. Practical Tip: Ask the supplier to specify the counterion and its approximate percentage. The counterion information is essential for accurate solution preparation. If the counterion is TFA (trifluoroacetic acid), consider using a protocol to remove it if it interferes with your downstream applications.

6. Endotoxin Levels

Description: Endotoxins are lipopolysaccharides (LPS) derived from the cell walls of Gram-negative bacteria. They are potent immune stimulants and can interfere with cell-based assays. Acceptable Range: For cell culture applications, the endotoxin level should be ? 10 EU/mg (Endotoxin Units per milligram) of peptide. For *in vivo* studies, even lower levels may be required. Analytical Method: The Limulus Amebocyte Lysate (LAL) assay is the standard method for detecting and quantifying endotoxins. Practical Tip: Request endotoxin testing data from the supplier, especially if the peptide will be used in cell culture or *in vivo* studies. Choose a supplier that offers endotoxin-free peptides or provides endotoxin removal services.

Common Impurities

Several impurities can be present in synthesized peptides. Understanding these impurities is crucial for interpreting research results and ensuring data accuracy. Common impurities include:

• Truncated Sequences: Peptides lacking one or more amino acids, typically due to incomplete coupling during synthesis.
• Deletion Sequences: Peptides missing one or more amino acids within the sequence.
• Modified Sequences: Peptides with unintended chemical modifications, such as oxidation of methionine residues or deamidation of asparagine or glutamine residues.
• Diastereomers: Peptides with incorrect stereochemistry at one or more chiral centers. This is more likely to occur when using non-chiral synthesis methods or when racemization occurs during synthesis.
• Protecting Group Derivatives: Residual protecting groups that were not completely removed during deprotection steps.
• Solvents and Reagents: Residual solvents (e.g., DMF, acetonitrile) and reagents (e.g., TFA) used during synthesis and purification.
• Counterions: As mentioned earlier, counterions are present in peptide salts.

Practical Tip: Request information about the synthesis and purification process from the supplier. A well-controlled synthesis process and rigorous purification procedures minimize the risk of impurities.

Storage Requirements

Proper storage is essential to maintain the integrity and stability of PT-141. The following guidelines are recommended:

• Temperature: Store the peptide at -20°C or -80°C in a freezer. Avoid repeated freeze-thaw cycles, as this can degrade the peptide. Aliquot the peptide into smaller portions to minimize freeze-thaw cycles.
• Desiccation: Store the peptide in a tightly sealed container with a desiccant (e.g., silica gel) to minimize water absorption.
• Light Protection: Protect the peptide from direct light exposure. Store the container in a dark place or wrap it in aluminum foil.
• Solution Storage: If the peptide is dissolved in a solution, store the solution at -20°C or -80°C in aliquots. Use a sterile, endotoxin-free buffer for dissolving the peptide.
• Inert Atmosphere: Consider storing the peptide under an inert atmosphere (e.g., argon or nitrogen) to minimize oxidation.

Practical Tip: Properly stored PT-141 can typically remain stable for 1-2 years. However, it's always advisable to check the peptide's integrity before use, especially if it has been stored for an extended period. Repeat HPLC analysis can be used to assess the peptide's purity and degradation.

Key Takeaways

• PT-141 (Bremelanotide) is a melanocortin receptor agonist under investigation for sexual dysfunction.
• Its mechanism of action involves activating MC3-R and MC4-R in the brain.
• Key quality markers include purity (? 98%), identity (confirmed by MS), peptide content (? 80%), water content (? 10%), and low endotoxin levels.
• Common impurities include truncated sequences, deletion sequences, and residual solvents.
• Proper storage at -20°C or -80°C with desiccation and light protection is crucial for maintaining stability.
• Always request comprehensive quality control data from the supplier before purchasing PT-141.